
Do new medicinal products need commercial exclusivity based on patent(s)? Conventional wisdom is 'yes', but for a recent new repurposed product for a rare disease, commercial exclusivity is actually derived mainly from the orphan designation, not patents. drugrepurposing.info/2022/09…







